{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:37:36Z","timestamp":1792431456945,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"DOI":"10.1007\/s10840-023-01684-9","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T06:02:28Z","timestamp":1699423348000},"page":"943-951","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Simultaneous subcutaneous implantable cardioverter-defibrillator and leadless pacemaker implantation for patients at high risk of infection: a retrospective case series report"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5938-1712","authenticated-orcid":false,"given":"Giuseppe M.","family":"Calvagna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Valsecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"issue":"43","key":"1684_CR1","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"2022","author":"K Zeppenfeld","year":"2022","unstructured":"Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, Charron P, Corrado D, Dagres N, de Chillou C, Eckardt L, Friede T, Haugaa KH, Hocini M, Lambiase PD, Marijon E, Merino JL, Peichl P, Priori SG, et al. ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;2022(43):3997\u20134126.","journal-title":"Eur Heart J."},{"issue":"42","key":"1684_CR2","first-page":"3599","volume":"2021","author":"MD TA","year":"2021","unstructured":"TA MD, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, JGF C, AJS C, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;2021(42):3599\u2013726.","journal-title":"Eur Heart J."},{"key":"1684_CR3","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jacc.2009.11.029","volume":"55","author":"DS Lee","year":"2010","unstructured":"Lee DS, Krahn AD, Healey JS, Birnie D, Crystal E, Dorian P, Simpson CS, Khaykin Y, Cameron D, Janmohamed A, Yee R, Austin PC, Chen Z, Hardy J, Tu JV. Investigators of the Ontario ICD Database. Evaluation of early complications related to de novo cardioverter defibrillator implantation insights from the Ontario ICD database. J Am Coll Cardiol. 2010;55:774\u201382.","journal-title":"J Am Coll Cardiol."},{"key":"1684_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.7326\/M15-2732","volume":"165","author":"I Ranasinghe","year":"2016","unstructured":"Ranasinghe I, Parzynski CS, Freeman JV, Dreyer RP, Ross JS, Akar JG, Krumholz HM, Curtis JP. Long-term risk for device-related complications and reoperations after implantable cardioverter-defibrillator implantation: an observational cohort study. Ann Intern Med. 2016;165:20\u20139.","journal-title":"Ann Intern Med."},{"key":"1684_CR5","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1093\/eurheartj\/ehx080","volume":"38","author":"MG Bongiorni","year":"2017","unstructured":"Bongiorni MG, Kennergren C, Butter C, Deharo JC, Kutarski A, Rinaldi CA, Romano SL, Maggioni AP, Andarala M, Auricchio A, Kuck KH, Blomstr\u00f6m-Lundqvist C, ELECTRa Investigators. The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) registry of transvenous lead extraction outcomes. Eur Heart J. 2017;38:2995\u20133005.","journal-title":"Eur Heart J."},{"key":"1684_CR6","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/eurheartj\/eht511","volume":"35","author":"RE Kirkfeldt","year":"2014","unstructured":"Kirkfeldt RE, Johansen JB, Nohr EA, J\u00f8rgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2014;35:1186\u201394.","journal-title":"Eur Heart J."},{"key":"1684_CR7","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1093\/europace\/euu147","volume":"16","author":"KG Tarakji","year":"2014","unstructured":"Tarakji KG, Wazni OM, Harb S, Hsu A, Saliba W, Wilkoff BL. Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infection type and the presence of vegetation on survival. Europace. 2014;16:1490\u20135.","journal-title":"Europace."},{"key":"1684_CR8","doi-asserted-by":"publisher","first-page":"e503","DOI":"10.1016\/j.hrthm.2017.09.001","volume":"14","author":"FM Kusumoto","year":"2017","unstructured":"Kusumoto FM, Schoenfeld MH, Wilkoff BL, Berul CI, Birgersdotter-Green UM, Carrillo R, Cha YM, Clancy J, Deharo JC, Ellenbogen KA, Exner D, Hussein AA, Kennergren C, Krahn A, Lee R, Love CJ, Madden RA, Mazzetti HA, Moore JC, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14:e503\u201351.","journal-title":"Heart Rhythm."},{"key":"1684_CR9","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.113.003042","volume":"128","author":"R Weiss","year":"2013","unstructured":"Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, Rashtian M, Kremers M, Crozier I, Lee KL, Smith W, Burke MC. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation. 2013;128:944\u201353.","journal-title":"Circulation."},{"key":"1684_CR10","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1093\/eurheartj\/ehab921","volume":"43","author":"PD Lambiase","year":"2022","unstructured":"Lambiase PD, Theuns DA, Murgatroyd F, Barr C, Eckardt L, Neuzil P, Scholten M, Hood M, Kuschyk J, Brisben AJ, Carter N, Stivland TM, Knops R, Boersma LVA. Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study. Eur Heart J. 2022;43:2037\u201350.","journal-title":"Eur Heart J."},{"key":"1684_CR11","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","volume":"72","author":"SM Al-Khatib","year":"2018","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018;72:e91\u2013e220.","journal-title":"J Am Coll Cardiol."},{"key":"1684_CR12","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.hrthm.2018.10.026","volume":"16","author":"S Viani","year":"2019","unstructured":"Viani S, Migliore F, Tola G, Pisan\u00f2 ECL, Russo AD, Luzzi G, Sartori P, Piro A, Rordorf R, Forleo GB, Rago A, Segreti L, Bertaglia E, Biffi M, Lovecchio M, Valsecchi S, Diemberger I, Bongiorni MG. Use and outcomes of subcutaneous implantable cardioverter-defibrillator (ICD) after transvenous ICD extraction: an analysis of current clinical practice and a comparison with transvenous ICD reimplantation. Heart Rhythm. 2019;16:564\u201371.","journal-title":"Heart Rhythm."},{"key":"1684_CR13","doi-asserted-by":"publisher","unstructured":"Giacomin E, Falzone PV, Dall'Aglio PB, Pittorru R, De Lazzari M, Vianello R, Bertaglia E, Tarzia V, Iliceto S, Gerosa G, Migliore F. Subcutaneous implantable cardioverter defibrillator after transvenous lead extraction: safety, efficacy and outcome. J Interv Card Electrophysiol. 2022; https:\/\/doi.org\/10.1007\/s10840-022-01293-y.","DOI":"10.1007\/s10840-022-01293-y"},{"key":"1684_CR14","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/pace.12955","volume":"39","author":"J Huang","year":"2016","unstructured":"Huang J, Patton KK, Prutkin JM. Concomitant use of the subcutaneous implantable cardioverter defibrillator and a permanent pacemaker. Pacing Clin Electrophysiol. 2016;39:1240\u20135.","journal-title":"Pacing Clin Electrophysiol."},{"key":"1684_CR15","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.amjcard.2014.10.036","volume":"115","author":"C Porterfield","year":"2015","unstructured":"Porterfield C, DiMarco JP, Mason PK. Effectiveness of implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with complete heart block and a pacemaker. Am J Cardiol. 2015;115:276\u20138.","journal-title":"Am J Cardiol."},{"key":"1684_CR16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10840-021-00966-4","volume":"63","author":"B Sarubbi","year":"2022","unstructured":"Sarubbi B, Colonna D, Correra A, Romeo E, D'Alto M, Palladino MT, Virno S, D'Onofrio A, Russo MG. Subcutaneous implantable cardioverter defibrillator in children and adolescents: results from the S-ICD \u201cMonaldi care\u201d registry. J Interv Card Electrophysiol. 2022;63:283\u201393.","journal-title":"J Interv Card Electrophysiol."},{"key":"1684_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/joa3.12666","volume":"38","author":"T Kajiyama","year":"2021","unstructured":"Kajiyama T, Kondo Y, Nakano M, Chiba T, Kobayashi Y. Concomitant use and interaction of a subcutaneous implantable defibrillator and epicardial pacemaker. J Arrhythm. 2021;38:155\u20136.","journal-title":"J Arrhythm."},{"key":"1684_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11936-016-0472-8","volume":"18","author":"H Rutzen-Lopez","year":"2016","unstructured":"Rutzen-Lopez H, Silva J, Helm RH. Leadless cardiac devices-pacemakers and implantable cardioverter-defibrillators. Curr Treat Options Cardiovasc Med. 2016;18:49.","journal-title":"Curr Treat Options Cardiovasc Med."},{"key":"1684_CR19","first-page":"1066.e5","volume":"33","author":"FZ Ahmed","year":"2017","unstructured":"Ahmed FZ, Cunnington C, Motwani M, Zaidi AM. Totally leadless dual-device implantation for combined spontaneous ventricular tachycardia defibrillation and pacemaker function: a first report. Can J Cardiol. 2017;33:1066.e5\u20137.","journal-title":"Can J Cardiol."},{"key":"1684_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/jce.13111","volume":"28","author":"JA Montgomery","year":"2017","unstructured":"Montgomery JA, Orton JM, Ellis CR. Feasibility of defibrillation and pacing without transvenous leads in a combined MICRA and S-ICD system following lead extraction. J Cardiovasc Electrophysiol. 2017;28:233\u20134.","journal-title":"J Cardiovasc Electrophysiol."},{"key":"1684_CR21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/joa3.12140","volume":"35","author":"JB Ng","year":"2018","unstructured":"Ng JB, Chua K, Teo WS. Simultaneous leadless pacemaker and subcutaneous implantable cardioverter-defibrillator implantation-when vascular options have run out. J Arrhythm. 2018;35:136\u20138.","journal-title":"J Arrhythm."},{"key":"1684_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jelectrocard.2019.06.001","volume":"56","author":"E Ljungstr\u00f6m","year":"2019","unstructured":"Ljungstr\u00f6m E, Brandt J, M\u00f6rtsell D, Borgquist R, Wang L. Combination of a leadless pacemaker and subcutaneous defibrillator with nine effective shock treatments during follow-up of 18\u00a0months. J Electrocardiol. 2019;56:1\u20133.","journal-title":"J Electrocardiol."},{"key":"1684_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.hrcr.2020.09.007","volume":"7","author":"GM Calvagna","year":"2020","unstructured":"Calvagna GM, Patan\u00e8 S, Romeo P. Transcatheter pacing system and leadless defibrillator: a solution in a complex case. A case report of a patient with previous device-related infection and persistent left-sided superior vena cava. HeartRhythm Case Rep. 2020;7:12\u20135.","journal-title":"HeartRhythm Case Rep."},{"key":"1684_CR24","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/europace\/euaa332","volume":"23","author":"G Fern\u00e1ndez-Palacios","year":"2021","unstructured":"Fern\u00e1ndez-Palacios G, Garc\u00eda-Mor\u00e1n E, Sand\u00edn-Fuentes M, Garc\u00eda-Granja PE, Rubio J, San Rom\u00e1n AJ. The utility of a combined synchronous atrioventricular leadless pacemaker and subcutaneous implantable cardiac defibrillator system in bilateral upper limb venous occlusion. Europace. 2021;23:814.","journal-title":"Europace."},{"key":"1684_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/europace\/euab232","volume":"24","author":"M Glikson","year":"2022","unstructured":"Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, Barrab\u00e9s JA, Boriani G, Braunschweig F, Brignole M, Burri H, Coats AJS, Deharo JC, Delgado V, Diller GP, Israel CW, Keren A, Knops RE, Kotecha D, et al. 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Europace. 2022;24:71\u2013164.","journal-title":"Europace."},{"key":"1684_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10840-018-0326-2","volume":"52","author":"P Francia","year":"2018","unstructured":"Francia P, Ziacchi M, De Filippo P, Viani S, D'Onofrio A, Russo V, Adduci C, Biffi M, Ferrari P, Bianchi V, Ammendola E, Palano F, Frisoni J, Valsecchi S, Lovecchio M, Bongiorni MG. Subcutaneous implantable cardioverter defibrillator eligibility according to a novel automated screening tool and agreement with the standard manual electrocardiographic morphology tool. J Interv Card Electrophysiol. 2018;52:61\u20137.","journal-title":"J Interv Card Electrophysiol."},{"key":"1684_CR27","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1093\/europace\/eup222","volume":"11","author":"GM Calvagna","year":"2009","unstructured":"Calvagna GM, Evola R, Scardace G, Valsecchi S. Single-operator experience with a mechanical approach for removal of pacing and implantable defibrillator leads. Europace. 2009;11:1505\u20139.","journal-title":"Europace."},{"key":"1684_CR28","doi-asserted-by":"publisher","unstructured":"Migliore F, Pittorru R, Giacomin E, Dall'Aglio PB, Falzone PV, Bertaglia E, Iliceto S, Gregori D, De Lazzari M, Corrado D. Intermuscular two-incision technique for implantation of the subcutaneous implantable cardioverter defibrillator: a 3-year follow-up. J Interv Card Electrophysiol. 2023; https:\/\/doi.org\/10.1007\/s10840-023-01478-z.","DOI":"10.1007\/s10840-023-01478-z"},{"key":"1684_CR29","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.hrthm.2013.05.016","volume":"10","author":"RE Knops","year":"2013","unstructured":"Knops RE, Olde Nordkamp LR, de Groot JR, Wilde AA. Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2013;10:1240\u20133.","journal-title":"Heart Rhythm."},{"key":"1684_CR30","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/europace\/euz246","volume":"22","author":"C Blomstr\u00f6m-Lundqvist","year":"2020","unstructured":"Blomstr\u00f6m-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC, Bongiorni MG, Poole J, Boriani G, Costa R, Deharo JC, Epstein LM, Saghy L, Snygg-Martin U, Starck C, Tascini C, Strathmore N. ESC Scientific Document Group. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Europace. 2020;22:515\u201349.","journal-title":"Europace"},{"key":"1684_CR31","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/pace.12518","volume":"38","author":"M Rizwan Sohail","year":"2015","unstructured":"Rizwan Sohail M, Henrikson CA, Jo Braid-Forbes M, Forbes KF, Lerner DJ. Increased long-term mortality in patients with cardiovascular implantable electronic device infections. Pacing Clin Electrophysiol. 2015;38:231\u20139.","journal-title":"Pacing Clin Electrophysiol."},{"key":"1684_CR32","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1001\/archinternmed.2011.441","volume":"171","author":"MR Sohail","year":"2011","unstructured":"Sohail MR, Henrikson CA, Braid-Forbes MJ, Forbes KF, Lerner DJ. Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med. 2011;171:1821\u20138.","journal-title":"Arch Intern Med."},{"key":"1684_CR33","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/europace\/euv053","volume":"17","author":"KA Polyzos","year":"2015","unstructured":"Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace. 2015;17:767\u201377.","journal-title":"Europace."},{"key":"1684_CR34","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1093\/eurheartj\/ehac496","volume":"43","author":"RE Knops","year":"2022","unstructured":"Knops RE, Pepplinkhuizen S, Delnoy PPHM, Boersma LVA, Kuschyk J, El-Chami MF, Bonnemeier H, Behr ER, Brouwer TF, Kaab S, Mittal S, Quast ABE, van der Stuijt W, Smeding L, de Veld JA, Tijssen JGP, Bijsterveld NR, Richter S, Brouwer MA, et al. Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial. Eur Heart J. 2022;43:4872\u201383.","journal-title":"Eur Heart J."},{"key":"1684_CR35","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1111\/jce.15080","volume":"32","author":"P Palmisano","year":"2021","unstructured":"Palmisano P, Ziacchi M, Ammendola E, D'Onofrio A, Dell'Era G, Laffi M, Biffi M, Nigro G, Bianchi W, Prenna E, Angeletti A, Guido A, Stronati G, Gaggioli G, Dello Russo A, Accogli M, Guerra F. Italian Association of Arrhythmology and Cardiac Pacing (AIAC). Rate and impact on patient outcome and healthcare utilization of complications requiring surgical revision: subcutaneous versus transvenous implantable defibrillator therapy. J Cardiovasc Electrophysiol. 2021;32:1712\u201323.","journal-title":"J Cardiovasc Electrophysiol."},{"key":"1684_CR36","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.hrthm.2022.07.031","volume":"19","author":"MR Gold","year":"2022","unstructured":"Gold MR, Aasbo JD, Weiss R, Burke MC, Gleva MJ, Knight BP, Miller MA, Schuger CD, Carter N, Leigh J, Brisben AJ, El-Chami MF. Infection in patients with subcutaneous implantable cardioverter-defibrillator: results of the S-ICD Post Approval Study. Heart Rhythm. 2022;19:1993\u20132001.","journal-title":"Heart Rhythm."},{"key":"1684_CR37","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.hrthm.2022.05.022","volume":"19","author":"MF El-Chami","year":"2022","unstructured":"El-Chami MF, Knight BP, Liu Y, Brisben AJ, Sohail MR, Griffiths RI. Temporal trends of device-related infection in de novo transvenous implantable cardioverter-defibrillator Medicare patients with underlying kidney disease. Heart Rhythm. 2022;19:1689\u201395.","journal-title":"Heart Rhythm."},{"key":"1684_CR38","doi-asserted-by":"crossref","unstructured":"De Filippo P, Migliore F, Palmisano P, Nigro G, Ziacchi M, Rordorf R, Pieragnoli P, Di Grazia A, Ottaviano L, Francia P, Pisan\u00f2 E, Tola G, Giammaria M, D\u2019Onofrio A, Botto GL, Zucchelli G, Ferrari P, Lovecchio M, Valsecchi S, Viani S. Procedure, management and outcome of subcutaneous implantable cardioverter-defibrillator extraction in clinical practice. Europace. 2023; In press","DOI":"10.1093\/europace\/euad158"},{"key":"1684_CR39","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.jacc.2007.01.072","volume":"49","author":"MR Sohail","year":"2007","unstructured":"Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Stoner S, Baddour LM. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007;49:1851\u20139.","journal-title":"J Am Coll Cardiol."},{"key":"1684_CR40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.hrthm.2018.07.006","volume":"16","author":"NEG Beurskens","year":"2019","unstructured":"Beurskens NEG, Tjong FVY, Dasselaar KJ, Kuijt WJ, Wilde AAM, Knops RE. Leadless pacemaker implantation after explantation of infected conventional pacemaker systems: a viable solution? Heart Rhythm. 2019;16:66\u201371.","journal-title":"Heart Rhythm."},{"key":"1684_CR41","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/jce.13851","volume":"30","author":"MF El-Chami","year":"2019","unstructured":"El-Chami MF, Johansen JB, Zaidi A, Faerestrand S, Reynolds D, Garcia-Seara J, Mansourati J, Pasquie JL, McElderry HT, Roberts PR, Soejima K, Stromberg K, Piccini JP. Leadless pacemaker implant in patients with pre-existing infections: results from the Micra postapproval registry. J Cardiovasc Electrophysiol. 2019;30:569\u201374.","journal-title":"J Cardiovasc Electrophysiol."},{"key":"1684_CR42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jacep.2019.10.017","volume":"6","author":"C Steinwender","year":"2020","unstructured":"Steinwender C, Khelae SK, Garweg C, Chan JYS, Ritter P, Johansen JB, Sagi V, Epstein LM, Piccini JP, Pascual M, Mont L, Sheldon T, Splett V, Stromberg K, Wood N, Chinitz L. Atrioventricular synchronous pacing using a leadless ventricular pacemaker: results from the MARVEL 2 study. JACC Clin Electrophysiol. 2020;6:94\u2013106.","journal-title":"JACC Clin Electrophysiol."},{"key":"1684_CR43","doi-asserted-by":"publisher","unstructured":"Knops RE, Reddy VY, Ip JE, Doshi R, Exner DV, Defaye P, Canby R, Bongiorni MG, Shoda M, Hindricks G, Neu\u017eil P, Rashtian M, Breeman KTN, Nevo JR, Ganz L, Hubbard C, Cantillon DJ. Aveir DR i2i Study Investigators. A dual-chamber leadless pacemaker. N Engl J Med. 2023; https:\/\/doi.org\/10.1056\/NEJMoa2300080.","DOI":"10.1056\/NEJMoa2300080"},{"key":"1684_CR44","doi-asserted-by":"publisher","unstructured":"Lloyd MS, Brisben AJ, Reddy VY, Blomstr\u00f6m-Lundqvist C, Boersma LVA, Bongiorni MG, Burke MC, Cantillon DJ, Doshi R, Friedman PA, Gras D, Kutalek SP, Neuzil P, Roberts PR, Wright DJ, Appl U, West J, Carter N, Stein KM, et al. Design and rationale of the modular ATP global clinical trial: a novel intercommunicative leadless pacing system and the subcutaneous implantable cardioverter defibrillator. Heart Rhythm O2. 2023; https:\/\/doi.org\/10.1016\/j.hroo.2023.05.004.","DOI":"10.1016\/j.hroo.2023.05.004"},{"key":"1684_CR45","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.hrthm.2022.01.024","volume":"19","author":"KTN Breeman","year":"2022","unstructured":"Breeman KTN, Swackhamer B, Brisben AJ, Quast ABE, Carter N, Shuros A, Soltis B, Koop BE, Burke MC, Wilde AAM, Tjong FVY, Knops RE. Long-term performance of a novel communicating antitachycardia pacing-enabled leadless pacemaker and subcutaneous implantable cardioverter-defibrillator system: a comprehensive preclinical study. Heart Rhythm. 2022;19:837\u201346.","journal-title":"Heart Rhythm."},{"key":"1684_CR46","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1056\/NEJMoa2206485","volume":"387","author":"P Friedman","year":"2022","unstructured":"Friedman P, Murgatroyd F, Boersma LVA, Manlucu J, O'Donnell D, Knight BP, Cl\u00e9menty N, Leclercq C, Amin A, Merkely BP, Birgersdotter-Green UM, Chan JYS, Biffi M, Knops RE, Engel G, Mu\u00f1oz Carvajal I, Epstein LM, Sagi V, Johansen JB, et al. Extravascular ICD Pivotal Study Investigators. Efficacy and safety of an extravascular implantable cardioverter-defibrillator. N Engl J Med. 2022;387:1292\u2013302.","journal-title":"N Engl J Med."},{"key":"1684_CR47","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1253\/circj.CJ-16-0153","volume":"80","author":"H Okamura","year":"2016","unstructured":"Okamura H, McLeod CJ, DeSimone CV, Webster TL, Bonnichsen CR, Grogan M, Phillips SD, Connolly HM, Ammash NM, Warnes CA, Friedman PA. Right parasternal lead placement increases eligibility for subcutaneous implantable cardioverter defibrillator therapy in adults with congenital heart disease. Circ J. 2016;80:1328\u201335.","journal-title":"Circ J."},{"key":"1684_CR48","doi-asserted-by":"publisher","unstructured":"ElRefai M, Abouelasaad M, Menexi C, Morgan J, Roberts PR. Impact of right ventricular pacing site on the subcutaneous ICD sensing-a step towards personalised device therapy? J Interv Card Electrophysiol. 2022; https:\/\/doi.org\/10.1007\/s10840-022-01218-9.","DOI":"10.1007\/s10840-022-01218-9"},{"key":"1684_CR49","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.tcm.2016.03.004","volume":"26","author":"ME Willcox","year":"2016","unstructured":"Willcox ME, Prutkin JM, Bardy GH. Recent developments in the subcutaneous ICD. Trends Cardiovasc Med. 2016;26:526\u201335.","journal-title":"Trends Cardiovasc Med."}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-023-01684-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-023-01684-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-023-01684-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T19:40:00Z","timestamp":1757101200000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-023-01684-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["1684"],"URL":"https:\/\/doi.org\/10.1007\/s10840-023-01684-9","relation":{},"ISSN":["1572-8595"],"issn-type":[{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,8]]},"assertion":[{"value":"26 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S. Valsecchi is an employee of Boston Scientific. The other author reports no conflicts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This was an independent study. No external funding was received for this project.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The data that support the findings of this study are available from the corresponding author upon reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}}]}}